Skip to main content
. Author manuscript; available in PMC: 2021 May 13.
Published in final edited form as: Acc Chem Res. 2019 Nov 13;52(12):3407–3418. doi: 10.1021/acs.accounts.9b00377

Figure 3.

Figure 3.

PrOF NMR titrations of (+)-JQ1 in BRD4-D1 labeled with (A) 5FW and (B) 3FY. (C) Screening of kinase inhibitors against mixtures of 5FW-BRD4-D1 and 5FW-BPTF (adapted with permission from refs 23 and 60. Copyright 2014 and 2015 American Chemical Society, respectively). (D) Bromodomain inhibitors and fragments characterized by PrOF NMR.23,61-63